Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03253211 · ClinicalTrials.gov registry record
Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 4,392
- Enrollment target
NCT03253211 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 4,392 participants.
The verdict
NCT03253211 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 4,392 participants
- Enrollment target
Study Summary
This project will improve the efficiency and quality of healthcare for persons with sickle cell disease, an under-served and at risk population by implementing a co-management model of care. Many patients with sickle cell disease (SCD) receive care primarily from specialty physicians and emergency departments (ED), thus resulting in a lack of primary care and a high number of ED visits and hospitalizations. The goal is to improve PCP and SCD specialist co-management. The overall purpose of this dissemination project is to evaluate utilization data, as well as patient and provider reported outcomes associated with the dissemination of a toolbox of decision support tools to PCP's and ED providers across NC and SC.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,392 participants |
| Start Date | 2018-11-06 |
| Est. Completion | 2019-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03253211
The ClinicalTrials.gov registry entry for NCT03253211 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,392 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03253211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03253211 about?
NCT03253211 is a clinical study titled "Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina". This project will improve the efficiency and quality of healthcare for persons with sickle cell disease, an under-served and at risk population by implementing a co-management model of care. Many patients with sickle cell disease (SCD) receive care primarily from specialty physicians and emergency d...
What is the current status of trial NCT03253211?
This trial is currently completed. The enrollment target is 4,392 participants. The study started on 2018-11-06. Estimated completion is 2019-12-15.
Who is sponsoring clinical trial NCT03253211?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.